chr19-43486286-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198850.4(PHLDB3):c.1465C>T(p.Pro489Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000216 in 1,610,594 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198850.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHLDB3 | NM_198850.4 | c.1465C>T | p.Pro489Ser | missense_variant | 13/16 | ENST00000292140.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHLDB3 | ENST00000292140.10 | c.1465C>T | p.Pro489Ser | missense_variant | 13/16 | 5 | NM_198850.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000289 AC: 70AN: 241884Hom.: 0 AF XY: 0.000320 AC XY: 42AN XY: 131208
GnomAD4 exome AF: 0.000213 AC: 311AN: 1458440Hom.: 1 Cov.: 34 AF XY: 0.000190 AC XY: 138AN XY: 725136
GnomAD4 genome AF: 0.000243 AC: 37AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2023 | The c.1465C>T (p.P489S) alteration is located in exon 13 (coding exon 12) of the PHLDB3 gene. This alteration results from a C to T substitution at nucleotide position 1465, causing the proline (P) at amino acid position 489 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at